Emergings in Brief (7/01)

Start-Up showcases the following recently-launched companies: ApoImmune Inc., Corus Pharma Inc., ImpactRx Inc. and Morewood Molecular Inc.

Showcasing very recently launched companies

ApoImmune Inc.

1044 East Chestnut Street

Louisville, KY 40217

• Phone: [phone]

• Fax: [phone]

• E-Mail: [email protected]

• Web Site: www.apoimmune.com

• Management: Bill Pearse, CEO; Haval Shirwan, PhD, Founder and Chief Scientist

• Company Founded: June 2001

• Partners/Alliances: University of Louisville School of Medicine

• Industry Segment: Biotechnology

• Business: Develops and markets products based on ProtEx, a platform technology developed at the University of Louisville that enables expression of any protein from any cell, tissue or organ without the use of viral vectors or the introduction of DNA. Expression can be accomplished within a two-hour period in a standard laboratory or hospital setting. The company's initial focus is therapeutic biologics for indications including cancer and graft-versus-host disease.

Corus Pharma Inc.

2025 1st Avenue, Suite 800

Seattle, WA 98121

• Phone: [phone]

• Fax: [phone]

• E-Mail: [email protected]

• Web Site: www.coruspharma.com

• Management: A. Bruce Montgomery, MD, Founder and CEO; Jonathan P. Mow, VP, Bus. Dev.; Iain W. Duncan, VP, Ops. and Human Resources; Nancy L. McKinley, Controller

• Company Founded: January 2001

• Financing to date: $18.5 million

• Investors: Burrill & Co.; JPMorgan Partners; OrbiMed Advisors; Cascade Investment; Digital Coast Ventures

• Employees: 10

• Industry Segment: Pharmaceuticals

• Business: Developing drugs to treat unmet needs in respiratory and infectious diseases. It has two lead development programs: one in sleep apnea and snoring; the second a treatment for respiratory infections including those found in patients with cystic fibrosis.

ImpactRx Inc.

307 Fellowship Road, Suite 300

Mt. Laurel, NJ 08054

• Phone: [phone]

• Fax: [phone]

• E-Mail: [email protected]

• Web Site: www.impactrx.com

• Management: Tim Margraf, Pres. and CEO; Gerry Gallivan, Chmn., Co-founder; Terry Overton, PhD, Senior Scientist, Co-founder; John Kain, VP, Sales; Peter Bittinger, VP, Information Technology; Gerhard Gallwitz, Senior Dir., Mktg. and Product Mgmt.

• Company Founded: September 2000

• Financing to Date: $9 million

• Investors: Oxford Bioscience Partners; Mediphase Venture Partners

• Employees: 32

• Industry Segment: Pharmaceuticals

• Business: Provides its pharmaceutical clients with a detailed analysis of the effects of their promotional efforts through its networks of high-prescribing physicians who provide real-time diagnosis, drug and promotion information.

Morewood Molecular Inc.

5001 Centre Avenue

Pittsburgh, PA 15213

• Phone: [phone]

• Fax: [phone]

• E-Mail: [email protected]

• Web Site: www.morewoodmolecular.com

• Management: Tom Petzinger, Co-founder and CEO; Jonathan Kaufman, PhD, Interim CSO

• Company Founded: June 2001

• Financing to Date: $500,000

• Investors: LaunchCyte LLC

• Employees: 3

• Partners/Alliances: LaunchCyte LLC; University of Pennsylvania

• Industry Segment: Biotechnology

• Business: Using a technology platform licensed from the University of Pennsylvania , the company aims to accelerate the drug discovery process with its rapid, ultra-high throughput test to measure enzyme activity in biological samples.